Lessons from rare diseases of cartilage and bone.

Abstract excerpt

Studying severe phenotypes of rare syndromes can elucidate disease mechanisms of more common disorders and identify potential therapeutic targets. Lessons from rare bone diseases contributed to the development of the most successful class of bone active agents, the bisphosphonates. More recent research on rare bone diseases has helped elucidate key pathways and identify new targets in bone resorption and bone...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bone Density Conservation Agents
• Share to Bone Diseases
• Share to Diphosphonates